CD38 and COVID-19: Using the calculation of relative frequencies of COVID-19 throughout the 6-month follow-up, the results were positive for the anti-CD20 group of patients (p = 0.031), but negative for the anti-CD38 (p =  > 0.9) and HSCT/CAR-T group (p = 0.2), respectively.